EMAIL THIS PAGE TO A FRIEND

The Journal of infectious diseases

Neuronal bioenergetics and acute mitochondrial dysfunction: a clue to understanding the central nervous system side effects of efavirenz.


PMID 24813473

Abstract

Neurological pathogenesis is associated with mitochondrial dysfunction and differences in neuronal/glial handling of oxygen and glucose. The main side effects attributed to efavirenz involve the CNS, but the underlying mechanisms are unclear. Human cell lines and rat primary cultures of neurons and astrocytes were treated with clinically relevant efavirenz concentration. Efavirenz alters mitochondrial respiration, enhances reactive oxygen species generation, undermines mitochondrial membrane potential, and reduces adenosine triphosphate (ATP) levels in a concentration-dependent fashion in both neurons and glial cells. However, it activates adenosine monophosphate-activated protein kinase only in glial cells, upregulating glycolysis and increasing intracellular ATP levels, which do not occur in neurons. To reproduce the conditions that often exist in human immunodeficiency virus-related neuroinflammatory disorders, the effects of efavirenz were evaluated in the presence of exogenous nitric oxide, an inflammatory mediator and mitochondrial inhibitor. The combination potentiated the effects on mitochondrial parameters in both neurons and glial cells, but ATP generation and lactate production were enhanced only in glial cells. Efavirenz affects the bioenergetics of neurons through a mechanism involving acute mitochondrial inhibition, an action exacerbated in neuroinflammatory conditions. A similar scenario of glial cells survival and degeneration of neurons with signs of mitochondrial dysfunction and oxidative stress has been associated with neurocognitive disorders.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB4300402
Anti-PRKAA1 (Ab-487) antibody produced in rabbit, affinity isolated antibody
SAB1406293
Anti-PRKAA1 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
SAB1412357
ANTI-PRKAA1 antibody produced in mouse, clone 3B6, purified immunoglobulin, buffered aqueous solution
SAB1412385
ANTI-PRKAA1 antibody produced in mouse, clone 4D8, purified immunoglobulin, buffered aqueous solution
AV53846
Anti-PRKAA1 antibody produced in rabbit, affinity isolated antibody
SAB2103747
Anti-PRKAA1 antibody produced in rabbit, affinity isolated antibody
SAB2107032
Anti-PRKAA1 antibody produced in rabbit, affinity isolated antibody
SAB3700853 Anti-Rabbit IgG (Fc specific), highly cross adsorbed-Peroxidase antibody produced in goat, affinity isolated antibody, lyophilized powder
SAB3700863 Anti-Rabbit IgG (Fc specific)-Peroxidase antibody produced in donkey, affinity isolated antibody, lyophilized powder
SAB3700852 Anti-Rabbit IgG (Fc specific)-Peroxidase antibody produced in goat, affinity isolated antibody, lyophilized powder
SAB3700949 Anti-Rabbit IgG (H+L), F(ab′)2 fragment-Peroxidase antibody produced in goat, affinity isolated antibody, lyophilized powder
SAB3700978 Anti-Rabbit IgG (H+L), F(ab) fragment-Peroxidase antibody produced in donkey, affinity isolated antibody, lyophilized powder
SAB3700972 Anti-Rabbit IgG (H+L), F(ab) fragment-Peroxidase antibody produced in goat, affinity isolated antibody, lyophilized powder
SAB3700941 Anti-Rabbit IgG (H+L)-Peroxidase antibody produced in chicken, affinity isolated antibody, lyophilized powder
SAB3700934 Anti-Rabbit IgG (H+L)-Peroxidase antibody produced in donkey, affinity isolated antibody, lyophilized powder
SAB3700920 Anti-Rabbit IgG (H+L)-Peroxidase antibody produced in sheep, affinity isolated antibody, lyophilized powder
SAB3700842
Anti-Rabbit IgG F(ab′)2, F(ab′)2 fragment, highly cross absorbed-Peroxidase antibody produced in goat, affinity isolated antibody, lyophilized powder
SAB3700832 Anti-Rabbit IgG F(ab′)2, highly cross adsorbed-Peroxidase antibody produced in goat, affinity isolated antibody, lyophilized powder
SAB3700831 Anti-Rabbit IgG F(ab′)2-Peroxidase antibody produced in goat, affinity isolated antibody, lyophilized powder
WH0005562M1
Monoclonal Anti-PRKAA1 antibody produced in mouse, clone 1G4, purified immunoglobulin, buffered aqueous solution
SAB1404236
Monoclonal Anti-PRKAA1 antibody produced in mouse, clone 4D9, purified immunoglobulin, buffered aqueous solution
SAB5300401 Monoclonal Anti-PRKAA1 antibody produced in mouse, clone 2B7, ascites fluid